Congenital left ventricular diverticulum: A rare cause of cardiac arrhythmia
We present two cases of a left ventricular diverticulum causing cardiac arrhythmia which led to furth er surgical treatment.
AbstractDonepezil, galantamine, and rivastigmine are the three acetylcholinesterase inhibitors (AChEIs), out of a total of only four medications prescribed in the treatment of Alzheimer's Disease (AD) and related dementias. These medications are known to be associated with bradycardia given their mechanism of action of increasing acetylcholine (ACh). However, in March 2015, donepezil was added to the CredibleMeds “known‐risk” category, a list where medications have a documented risk for acquired long‐QT syndrome (ALQTS) and torsades de pointes (TdP) – a malignant ventricular arrhythmia that is a diffe...
ConclusionsIn this global survey of> 1100 EP professionals regarding hospitalized COVID-19 patients, a variety of arrhythmic manifestations were observed, ranging from benign to potentially life-threatening. Observed adverse events related to use of HCQ + AZM included prolonged QTc requiring drug discontinuation as well as Torsade d e Pointes. Large prospective studies to better define arrhythmic manifestations as well as the safety of treatment strategies in COVID-19 patients are warranted.
Implantable cardioverter defibrillator (ICD) implantation is a life-saving procedure in patients at risk of malignant ventricular arrhythmia. However, recurrent ICD shocks increase morbidity and mortality and decrease quality of life.
Commonest cause of SCD due to cardiac arrhythmia – MCQ – Answer Commonest cause of sudden death due to cardiac arrhythmia – Correct answer: d) Coronary artery disease Though all the rest are primary electrical disorders of the heart with high risk of arrhythmic death, their prevalence is quite low compared to coronary artery disease. Hence ventricular fibrillation secondary to acute myocardial infarction/ischemia and previous myocardial infarction with scar related re-entrant ventricular arrhythmia together contribute a much larger number of sudden arrhythmic deaths in the community. Back to question
Sudden cardiac death continues to be a major cause of death in patients with structural heart disease, and accounts for approximately 50% of total cardiovascular mortality. To prevent sudden cardiac death, current guidelines recommend that patients with heart failure and reduced left ventricular systolic function receive primary prevention cardioverter-defibrillator (ICD) devices, with supporting evidence from multiple clinical trials.1 For over two centuries, thyroid disease and cardiac arrhythmias have been shown to be closely associated.
This study aimed to compare the risk of fractures, acute myocardial infarction, atrial fibrillation, and ventricular arrhythmia among Danish citizens aged ≥ 65 which were new users of promethazine or domperidone, triazolam, loratadine, and betahistine. Secondly, the study aimed to perform a risk stratification to identify the most relevant predictors for the study outcomes.Methods: The study period was 01/01/2015 to 31/12/2016. The data sources were the Danish registers. Each patient was followed for 90 days. A logistic regression model was used to compute the unadjusted and adjusted odds ratios (OR), and a conditional ...
AbstractCatheter ablation is a well-recognized treatment for a number of cardiac arrhythmias. Initially used to treat supraventricular tachycardia, this technique is now also widely used to treat ventricular arrhythmia and atrial fibrillation. This review aims to describe all the possible types of complication related to this i nvasive procedure. Definitions according to the current guidelines are provided, as are some details on the frequency of complications and how to diagnose and treat them appropriately. Finally, each section of the review provides guidance on how to prevent the complications associated with catheter ablation.
CONCLUSION: Collectively, these findings suggest that the increased ventricular arrhythmia susceptibility of type 2 diabetic mouse hearts is due to dysregulation of the sympathetic ventricular control. PMID: 31625779 [PubMed - as supplied by publisher]
AbstractLong QT syndrome (LQTS) is an inherited primary arrhythmia syndrome that may present with malignant arrhythmia and, rarely, risk of sudden death. The clinical symptoms include palpitations, syncope, and anoxic seizures secondary to ventricular arrhythmia, classicallytorsade de pointes. This predisposition to malignant arrhythmia is from a cardiac ion channelopathy that results in delayed repolarization of the cardiomyocyte action potential. The QT interval on the surface electrocardiogram is a summation of the individual cellular ventricular action potential durations, and hence is a surrogate marker of the abnorma...
In conclusion, we identified a novel hERG channel activator HW-0168 that can be used for studying the physiological role of hERG in cardiac myocytes and may be beneficial for treating long QT syndrome.